During the 2025 financial year, no changes were made to the share capital.
As of December 31, 2025, the share capital totaled euro 101,724,744 divided into 254,311,860 fully paid-up shares with a nominal value of euro 0.40, of which 24,053,529 shares carried double voting rights.
| Type of delegation or authorization | Date of the Meeting | Term of delegation/expiry | Amount authorized | Usage in 2025 |
|---|---|---|---|---|
| Share buybacks | ||||
|
Authorization to trade in the Company’s shares* |
Authorization to trade in the Company’s shares* Date of the Meeting May 27, 2025 (17th resolution) |
Authorization to trade in the Company’s shares* Term of delegation/expiry 18 months/ November 27, 2026** |
Authorization to trade in the Company’s shares* Amount authorized No more than 10% of the share capital Maximum total amount: €2,154,430,476.50 Maximum unit purchase price: €130 |
Authorization to trade in the Company’s shares* Usage in 2025 See details in Section 8.3.3 |
|
Cancellation of shares |
||||
|
Authorization to reduce share capital through the cancellation of treasury shares |
Authorization to reduce share capital through the cancellation of treasury shares Date of the Meeting May 27, 2025 (18th resolution) |
Authorization to reduce share capital through the cancellation of treasury shares Term of delegation/expiry 26 months/ July 27, 2027 |
Authorization to reduce share capital through the cancellation of treasury shares Amount authorized No more than 10% of capital per 24-month period |
Authorization to reduce share capital through the cancellation of treasury shares Usage in 2025 None |
|
Equity issues |
||||
|
Delegation to increase the share capital by issuing shares or securities giving access to the capital, with preferential subscription rights* |
Delegation to increase the share capital by issuing shares or securities giving access to the capital, with preferential subscription rights* Date of the Meeting May 29, 2024 (16th resolution) |
Delegation to increase the share capital by issuing shares or securities giving access to the capital, with preferential subscription rights* Term of delegation/expiry 26 months/ July 29, 2026** |
Delegation to increase the share capital by issuing shares or securities giving access to the capital, with preferential subscription rights* Amount authorized Maximum nominal amount: €30,000,000(1) Maximum nominal amount of debt securities: €1,200,000,000(2) |
Delegation to increase the share capital by issuing shares or securities giving access to the capital, with preferential subscription rights* Usage in 2025 None |
|
Delegation to increase share capital by issuing shares or equity securities giving access to the capital, without preferential subscription rights, through public offerings other than those made pursuant to article L. 411-2 of the French Monetary and Financial Code* |
Delegation to increase share capital by issuing shares or equity securities giving access to the capital, without preferential subscription rights, through public offerings other than those made pursuant to article L. 411-2 of the French Monetary and Financial Code* Date of the Meeting May 29, 2024 (17th resolution) |
Delegation to increase share capital by issuing shares or equity securities giving access to the capital, without preferential subscription rights, through public offerings other than those made pursuant to article L. 411-2 of the French Monetary and Financial Code* Term of delegation/expiry 26 months/ July 29, 2026** |
Delegation to increase share capital by issuing shares or equity securities giving access to the capital, without preferential subscription rights, through public offerings other than those made pursuant to article L. 411-2 of the French Monetary and Financial Code* Amount authorized Maximum nominal amount: €9,000,000(1)(3) Maximum nominal amount of debt securities: €1,200,000,000(2) |
Delegation to increase share capital by issuing shares or equity securities giving access to the capital, without preferential subscription rights, through public offerings other than those made pursuant to article L. 411-2 of the French Monetary and Financial Code* Usage in 2025 None |
|
Delegation to increase share capital by issuing shares or equity securities giving access to the capital, without preferential subscription rights, through public offerings made pursuant to paragraph I of article L. 411-2 1° of the French Monetary and Financial Code* |
Delegation to increase share capital by issuing shares or equity securities giving access to the capital, without preferential subscription rights, through public offerings made pursuant to paragraph I of article L. 411-2 1° of the French Monetary and Financial Code* Date of the Meeting May 29, 2024 (18th resolution) |
Delegation to increase share capital by issuing shares or equity securities giving access to the capital, without preferential subscription rights, through public offerings made pursuant to paragraph I of article L. 411-2 1° of the French Monetary and Financial Code* Term of delegation/expiry 26 months/ July 29, 2026** |
Delegation to increase share capital by issuing shares or equity securities giving access to the capital, without preferential subscription rights, through public offerings made pursuant to paragraph I of article L. 411-2 1° of the French Monetary and Financial Code* Amount authorized Maximum nominal amount: €9,000,000(1)(3) Maximum nominal amount of debt securities: €1,200,000,000(2) |
Delegation to increase share capital by issuing shares or equity securities giving access to the capital, without preferential subscription rights, through public offerings made pursuant to paragraph I of article L. 411-2 1° of the French Monetary and Financial Code* Usage in 2025 None |
|
Delegation to increase the number of securities to be issued in the event of a capital increase decided pursuant to the 16th to 18th resolutions of the General Shareholders’ Meeting of May 29, 2024* |
Delegation to increase the number of securities to be issued in the event of a capital increase decided pursuant to the 16th to 18th resolutions of the General Shareholders’ Meeting of May 29, 2024* Date of the Meeting May 29, 2024 (19th resolution) |
Delegation to increase the number of securities to be issued in the event of a capital increase decided pursuant to the 16th to 18th resolutions of the General Shareholders’ Meeting of May 29, 2024* Term of delegation/expiry 26 months/ July 29, 2026** |
Delegation to increase the number of securities to be issued in the event of a capital increase decided pursuant to the 16th to 18th resolutions of the General Shareholders’ Meeting of May 29, 2024* Amount authorized No more than 15%(1)(3) of the initial issue and at the same price as this issue |
Delegation to increase the number of securities to be issued in the event of a capital increase decided pursuant to the 16th to 18th resolutions of the General Shareholders’ Meeting of May 29, 2024* Usage in 2025 None |
|
Authorization to set the issue price of equity securities as part of capital increases issued without preferential subscription rights, pursuant to the 17th and 18th resolutions of the General Shareholders’ Meeting of May 29, 2024* |
Authorization to set the issue price of equity securities as part of capital increases issued without preferential subscription rights, pursuant to the 17th and 18th resolutions of the General Shareholders’ Meeting of May 29, 2024* Date of the Meeting May 29, 2024 (20th resolution) |
Authorization to set the issue price of equity securities as part of capital increases issued without preferential subscription rights, pursuant to the 17th and 18th resolutions of the General Shareholders’ Meeting of May 29, 2024* Term of delegation/expiry 26 months/ July 29, 2026*** |
Authorization to set the issue price of equity securities as part of capital increases issued without preferential subscription rights, pursuant to the 17th and 18th resolutions of the General Shareholders’ Meeting of May 29, 2024* Amount authorized No more than 10% of the share capital per year(1)(3) |
Authorization to set the issue price of equity securities as part of capital increases issued without preferential subscription rights, pursuant to the 17th and 18th resolutions of the General Shareholders’ Meeting of May 29, 2024* Usage in 2025 None |